If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

2019
48 Downloads (Pure)

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm A single-case report

Iversen, K. F., Holdgaard, P. C., Preiss, B., Nyvold, C. G. & Plesner, T., Sep 2019, In : Haematologica. 104, 9, p. e432-e433

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
13 Downloads (Pure)

Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma

MAIA Trial Investigators & Abildgaard, N., 30. May 2019, In : New England Journal of Medicine. 380, 22, p. 2104-2115

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Control Groups
Confidence Intervals
Neutropenia
daratumumab
Lymphopenia

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

Plesner, T., Arkenau, H. T., Gay, F., Minnema, M. C., Boccadoro, M., Moreau, P., Cavenagh, J., Perrot, A., Laubach, J. P., Krejcik, J., Ahmadi, T., de Boer, C., Chen, D., Chiu, C., Schecter, J. M. & Richardson, P. G., Aug 2019, In : British Journal of Haematology. 186, 3, p. e35-e39

Research output: Contribution to journalLetterResearchpeer-review

EUROPEAN PATIENT SAFETY POST-AUTHORIZATION STUDY WITH MULTIPLE REFRACTORY MYELOMA OR IN RELAPSE TREATED WITH POMALIDOMIDE IN HABITUAL PRACTICE

Payer, AR., Gamberi, B., Abildgaard, N., Vekemans, MC., Kyriakou, C., Di Raimondo, F., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., 24. Oct 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

European Post-Authorization Safety Study of Patients With Relapsed or Refractory Multiple Myeloma Treated With Pomalidomide in a Real-World Setting

Gamberi, B., Abildgaard, N., Vekemans, M-C., Ramirez Payer, A., Kyriakou, C., Di Raimondo, F., Kueenburg, E. ., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., Sep 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

European Post-Authorization Safety Study of Patients With Relapsed or Refractory Multiple Myeloma Treated With Pomalidomide in a Real-World Setting

Gamberi, B., Abildgaard, N., Vekemans, M-C., Ramirez Payer, A., Kyriakou, C., Di Raimondo, F., Kueenburg, E. ., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., Oct 2019, In : Clinical Lymphoma, Myeloma & Leukemia. 19, 10 Suppl., p. e256 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

103 Downloads (Pure)

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Adams, H. C., Stevenaert, F., Krejcik, J., Van der Borght, K., Smets, T., Bald, J., Abraham, Y., Ceulemans, H., Chiu, C., Vanhoof, G., Usmani, S. Z., Plesner, T., Lonial, S., Nijhof, I., Lokhorst, H. M., Mutis, T., van de Donk, N. W. C. J., Sasser, A. K. & Casneuf, T., 1. Mar 2019, In : Cytometry. Part A. 95, 3, p. 279-289

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Granzymes
Flow Cytometry
Population
Immunophenotyping
Plasma Cells

POMALIDOMIDE-BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WHO DIED IN THE EUROPEAN POST APPROVAL SAFETY STUDY

Gamberi, B., Abildgaard, N., Ramirez Payer, A., Kyriakou, C., Schmidt Hieber, M., Di Raimondo, F., Kueenburg, E. ., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., Jun 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

POMALIDOMIDE-BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WHO DIED IN THE EUROPEAN POST APPROVAL SAFETY STUDY

Gamberi, B., Abildgaard, N., Ramirez Payer, A., Kyriakou, C., Schmidt Hieber, M., Di Raimondo, F., Kueenburg, E. ., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P. & Plesner, T., Jun 2019, In : HemaSphere. 3

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

Usmani, S. Z., Nahi, H., Mateos, M-V., van de Donk, N. W. C. J., Chari, A., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., Hellemans, P., Masterson, T., Clemens, P. L., Luo, M., Liu, K. & San Miguel, J., 22. Aug 2019, In : Blood. 134, 8, p. 668-677

Research output: Contribution to journalJournal articleResearchpeer-review

Hyaluronoglucosaminidase
Pharmacokinetics
Enzymes
daratumumab
Safety

Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

Redder, L., Klausen, T. W., Vangsted, A. J., Gregersen, H., Andersen, N. F., Pedersen, R. S., Plesner, T., Frederiksen, M., Frølund, U. C., Helleberg, C., Kongsgaard Nielsen, L., Salomo, M., Gimsing, P., Frederiksen, H. & Abildgaard, N., 13. Nov 2019, In : Blood. 134, Supplement 1, 1849.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

Redder, L., Klausen, T. W., Vangsted, A. J., Gregersen, H., Andersen, N. F., Pedersen, R. S., Plesner, T., Frølund, U. C., Helleberg, C., Kongsgaard Nielsen, L., Salomo, M., Gimsing, P., Frederiksen, H., Abildgaard, N. & Frederiksen, M., 13. Nov 2019.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

“Fine-tuning cytoreduction in resistant multiple myeloma - progress here, too”?

Plesner, T., Nov 2019, In : British Journal of Haematology. 187, 3, p. 275-276

Research output: Contribution to journalEditorialResearchpeer-review

2018
105 Downloads (Pure)

Daratumumab for the treatment of multiple myeloma

Plesner, T. & Krejcik, J., 4. Jun 2018, In : Frontiers in Immunology. 9, 6 p., 1228.

Research output: Contribution to journalReviewResearchpeer-review

Open Access
File
daratumumab

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Schmidt-Hieber, M., Abildgaard, N., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Froen, H. F., Izarra, A. I., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 15. Jun 2018, In : EHA Learning Center.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Schmidt-Hieber, M., Abildgaard, N., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Froen, H. F., Izarra, A. I., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 15. Jun 2018.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Inclusion body myositis and T cell large granular lymphocytic leucaemia: An underestimated coexistence of two severe disorders

Morillon, M., Iversen, K. F., korsgaard, S., Plesner, T. & Diederichsen, L. C. P. R., 1. Sep 2018.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

97 Downloads (Pure)

Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

Yan, X., Clemens, P. L., Puchalski, T., Lonial, S., Lokhorst, H., Voorhees, P. M., Usmani, S., Richardson, P. G., Plesner, T., Liu, K., Orlowski, R. Z., Losic, N., Jansson, R., Ahmadi, T., Lantz, K., Ruixo, J. J. P., Zhou, H. & Xu, X. S., 2018, In : Clinical Pharmacokinetics. 57, 4, p. 529-538

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
daratumumab
Albumins
Odds Ratio
Confidence Intervals
Kidney

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Abildgaard, N., Vekemans, M-C., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Kentos, A., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 2. Dec 2018.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Abildgaard, N., Vekemans, M-C., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Kentos, A., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 2. Dec 2018, In : Blood. 132, Suppl.1, p. 3286 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

2017
147 Downloads (Pure)

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma

Xu, X. S., Yan, X., Puchalski, T., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Plesner, T., Liu, K., Khan, I., Jansson, R., Ahmadi, T., Perez Ruixo, J. J., Zhou, H. & Clemens, P. L., 2017, In : Clinical Pharmacology & Therapeutics. 101, p. 721-724

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Pharmacokinetics
Pharmaceutical Preparations
daratumumab

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma

Casneuf, T., Xu, X. S., Adams, H. C., Axel, A. E., Chiu, C., Khan, I., Ahmadi, T., Yan, X., Lonial, S., Plesner, T., Lokhorst, H. M., van de Donk, N. W. C. J., Clemens, P. L. & Sasser, A. K., 24. Oct 2017, In : Blood Advances. 1, 23, p. 2105-2114

Research output: Contribution to journalJournal articleResearchpeer-review

Safety
daratumumab
Infection Control
Clinical Trials
Neoplasms

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study

Sezer, O., Beksac, M., Hajek, R., Sucak, G., Cagirgan, S., Linkesch, W., Meltem Akay, O., Gülbas, Z., Nahi, H., Plesner, T., Snowden, J. A., Timurağaoğlu, A., Dechow, T., Lang, A., Tuğlular, T., Drach, J., Armbrecht, G., Potamianou, A., Couturier, C., Olie, R. A. & 3 others, Feys, C., Allietta, N. & Terpos, E., Jul 2017, In : British Journal of Haematology. 178, 1, p. 61-71

Research output: Contribution to journalJournal articleResearchpeer-review

Observation
Peripheral Nervous System Diseases
Bone Density
Disease-Free Survival
Bortezomib

FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy

Østergaard, B., Shamchi, S. P., Taghvaei, R., Zirakchian, M. Z., Raynor, W., Nielsen, A. L., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 1. Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., p. 483-484 EP-0127.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy

Østergaard, B., Shamchi, S. P., Taghvaei, R., Zirakchian, M. Z., Raynor, W., Nielsen, A. L., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 21. Oct 2017, p. 483-484.

Research output: Contribution to conference without publisher/journalPosterResearch

FDG-PET/CT in multiple myeloma: dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy

Østergaard, B., Taghvaei, R., Nielsen, A. L., Zirakchian, M. Z., Raynor, W., Asmussen, J. T., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 1. Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., p. 483 1 p., WHO 2016 C.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

FDG-PET/CT in multiple myeloma: dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy

Østergaard, B., Taghvaei, R., Nielsen, A. L., Zirakchian, M. Z., Raynor, W., Asmussen, J. T., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 10. Dec 2017, p. 483. 1 p.

Research output: Contribution to conference without publisher/journalPosterResearch

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Stege, C. A. M., Sonneveld, P., Plesner, T., Stevens-Kroef, M., van der Holt, B., Zweegman, S., Waage, A., Klein, S., Sinnige, H., Mellqvist, U-H., Abildgaard, N., Durian, M. F., Hansson, M., Levin, M-D., Leijs, M. B., Szatkowski, D. L., Haukås, E., Salomo, M., Bos, G., Visser-Wisselaar, H. & 11 others, van der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Tanis, B., Brouwer, R., Westerman, M., van der Hem, K., Mattijssen, V., Gimsing, P. & Van De Donk, N. WCJ., 10. Dec 2017.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Stege, C. A. M., van der Holt, B., Mellqvist, U-H., Levin, M-D., Salomo, M., Abildgaard, N., Bos, G., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M., Leijs, M. B. & 11 others, Sinnige, H., Haukås, E., van der Hem, K., Durian, M. F., Mattijssen, V., Gimsing, P., Van De Donk, N. WCJ., Stevens-Kroef, M., Sonneveld, P., Waage, A. & Zweegman, S., 2017, In : Blood. 130, Suppl. 1, 3146.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab

Krejcik, J., Frerichs, K. A., Nijhof, I. S., van Kessel, B., van Velzen, J., Bloem, A. C., Broekmans, M., Zweegman, S., van Meerloo, J., Musters, R. J., Poddighe, P., Groen, R., Chiu, C., Plesner, T., Lokhorst, H. M., Sasser, A. K., Mutis, T. & van de Donk, N. W. C. J., 2017, In : Clinical Cancer Research. 23, 24, p. 7498-7511

Research output: Contribution to journalJournal articleResearchpeer-review

daratumumab
Membrane Proteins
Cell Membrane
In Vitro Techniques

NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group

Østergaard, B., Zadeh, M., Raynor, W., Taghvaei, R., Nielsen, A. L., Holdgaard, P. C., Asmussen, J. T., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, Suppl. 2, p. 484 1 p., EP-0128.

Research output: Contribution to journalConference abstract in journalResearch

NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group

Østergaard, B., Zadeh, M., Raynor, W., Taghvaei, R., Nielsen, A. L., Asmussen, J. T., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., p. 484-485 EP-0128.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma: results of the HOVON87/NMSG18 study

Stege, C. A. M., Kongsgaard Nielsen, L., Witte, B., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Gruber, A., Coenen, J., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M. & 14 others, Leys, R., Sinnige, H., Haukås, E., van der Hem, K., Durian, M., Mattijssen, V., Mattijssen, V., Gimsing, P., van de Donk, N., Stevens-Kroef, M., Sonneveld, P., Waage, A., Zweegman, S. & Abildgaard, N., 2017, In : Haematologica. 102, S2, p. 190 1 p., S501.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

90 Downloads (Pure)

Response to: Interference of daratumumab on the serum protein electrophoresis

McCudden, C., Axel, A. E., Slaets, D., Dejoie, T., Clemens, P., Frans, S., Bald, J., Plesner, T., Jacobs, J. F. M., van de Donk, N. W. C. J., Moreau, P., Schecter, J. M., Ahmadi, T. & Sasser, A. K., 2017, In : Clinical Chemistry and Laboratory Medicine. 55, 2, p. e29-e30

Research output: Contribution to journalComment/debateResearchpeer-review

Open Access
File
99 Downloads (Pure)

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

Hillengass, J., Moulopoulos, L. A., Delorme, S., Koutoulidis, V., Mosebach, J., Hielscher, T., Drake, M., Rajkumar, S. V., Oestergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Withofs, N., Caers, J., Waage, A., Goldschmidt, H., Dimopoulos, M. A., Lentzsch, S. & 2 others, Durie, B. & Terpos, E., 2017, In : Blood Cancer Journal. 7, 8, 6 p., e599.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Surveys and Questionnaires
Skeleton
Positron Emission Tomography Computed Tomography
2016

18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones

Østergaard, B., Nielsen, A. L., Møller, H. E. H., Preiss, B. S., Asmussen, J. T., Mortensen, J. R., Plesner, T., Gerke, O., Alavi, A., Høilund-Carlsen, P. F. & Abildgaard, N., 2016.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones

Østergaard, B., Nielsen, A. L., Møller, H. E. H., Preiss, B. S., Asmussen, J. T., Mortensen, J. R., Plesner, T., Gerke, O., Alavi, A., Høilund-Carlsen, P. F. & Abildgaard, N., 2016, In : Blood. 128, 22, 3260.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

89 Downloads (Pure)

Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients

Hinge, M., Andersen, K. T., Lund, T., Jørgensen, H. B., Holdgaard, P. C., Ormstrup, T. E., Lange Østergaard, L. & Plesner, T., 2016, In : Haematologica. 101, p. e415-e418

Research output: Contribution to journalComment/debateResearchpeer-review

Open Access
File
98 Downloads (Pure)

Bone healing in multiple myeloma: A prospective evaluation of the impact of first-line anti-myeloma treatment

Hinge, M., Andersen, K. T., Lund, T., Jørgensen, H. B., Holdgaard, P. C., Ormstrup, T. E., Lange Østergaard, L. & Plesner, T., 2016, In : Haematologica. 101, 10, p. e419-e422

Research output: Contribution to journalComment/debateResearchpeer-review

Open Access
File

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma

van de Donk, N. W. C. J., Moreau, P., Plesner, T., Palumbo, A., Gay, F., Laubach, J. P., Malavasi, F., Avet-Loiseau, H., Mateos, M-V., Sonneveld, P., Lokhorst, H. M. & Richardson, P. G., 11. Feb 2016, In : Blood. 127, 6, p. 681-695

Research output: Contribution to journalJournal articleResearchpeer-review

Plasma Cells
Disease-Free Survival
Pharmaceutical Preparations
daratumumab
elotuzumab

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

Usmani, S. Z., Weiss, B. M., Plesner, T., Bahlis, N. J., Belch, A., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Richardson, P. G., Chari, A., Sasser, A. K., Axel, A., Feng, H., Uhlar, C. M., Wang, J., Khan, I., Ahmadi, T. & Nahi, H., 23. May 2016, In : Blood. 128, 1, p. 37-44

Research output: Contribution to journalJournal articleResearchpeer-review

Confidence Intervals
Proteasome Inhibitors
Disease-Free Survival
Safety
daratumumab
372 Downloads (Pure)

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Dimopoulos, M. A., Oriol, A., Nahi, H., San-Miguel, J., Bahlis, N. J., Usmani, S. Z., Rabin, N., Orlowski, R. Z., Komarnicki, M., Suzuki, K., Plesner, T., Yoon, S-S., Ben Yehuda, D., Richardson, P. G., Goldschmidt, H., Reece, D., Lisby, S., Khokhar, N. Z., O'Rourke, L., Chiu, C. & 5 others, Qin, X., Guckert, M., Ahmadi, T., Moreau, P. & POLLUX Investigators, 6. Oct 2016, In : The New England Journal of Medicine. 375, 14, p. 1319-1331

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Control Groups
Disease-Free Survival
Residual Neoplasm
Confidence Intervals
Neutropenia

Daratumumab depletes CD38+ immune-regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

Krejcik, J., Casneuf, T., Nijhof, I. S., Verbist, B., Bald, J., Plesner, T., Syed, K., Liu, K., van de Donk, N. W. C. J., Weiss, B. M., Ahmadi, T., Lokhorst, H. M., Mutis, T. & Sasser, A. K., 24. May 2016, In : Blood. 128, 3, p. 384-394

Research output: Contribution to journalJournal articleResearchpeer-review

T-Cell Antigen Receptor
Immunosuppressive Agents
Regulatory B-Lymphocytes
CD4-CD8 Ratio
daratumumab

Djøgeunger: Djøgen er en mærkelig fugl. Den lægger sine æg i andre fugles reder og expanderer sin art uden at kere sig om biodiversitet

Plesner, T., 10. Aug 2016

Research output: Other contributionNet publication - Internet publicationCommunication

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma

Mateos, M-V., Granell, M., Oriol, A., Martínez-López, J., Bladé, J., Hernandez, M. T., Martín, J., Gironella, M., Lynch, M., Bleickardt, E., Paliwal, P., Singhal, A., San-Miguel, J. & Plesner, T., Nov 2016, In : British Journal of Haematology. 175, 3, p. 448-456 9 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Safety
Disease-Free Survival
elotuzumab
Survival Rate
Population

Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Moreau, P., van de Donk, N. W. C. J., Miguel, J. S., Lokhorst, H., Nahi, H., Ben-Yehuda, D., Cavo, M., Cook, G., Delforge, M., Einsele, H., Zweegman, S., Ludwig, H., Driessen, C., Palumbo, A., Facon, T., Plesner, T., Dimopoulos, M., Sondergeld, P., Sonneveld, P. & Mateos, M-V., Jun 2016, In : Drugs. 76, 9, p. 989-990

Research output: Contribution to journalComment/debateResearchpeer-review

Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies

Blau, I-W., Conlon, N., Petermann, R., Nikolov, N. & Plesner, T., Jul 2016, In : Expert Review of Clinical Immunology. 12, 7, p. 705-711

Research output: Contribution to journalJournal articleResearchpeer-review

Hematologic Neoplasms
Survival Rate

FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma

Østergaard, B., Nielsen, A. L., Gerke, O., Mortensen, J. R., Asmussen, J. T., Plesner, T., Ormstrup, T., Holdgaard, P. C., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2016, In : European Journal of Nuclear Medicine and Molecular Imaging. 43, 1 Suppl. 1, p. S438 1 p., EP559.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma

Østergaard, B., Nielsen, A. L., Gerke, O., Mortensen, J. R., Asmussen, J. T., Plesner, T., Ormstrup, TE., Holdgaard, P. C., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2016.

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders: a Study of the International Myeloma Working Group

Hillengass, J., Monopoulos, L. A., Delorme, S., Koutoulidis, V., Hielscher, T., Engelhart, J., Drake, M. T., Rajkumar, V., Østergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Caers, J., Withofs, N., Dimopoulos1, M., Goldschmidt, H., Lentzsch, S., Durie, B. G. & 1 others, Terpos, E., 2016, In : Blood. 128, 22, 4468.

Research output: Contribution to journalConference abstract in journalResearchpeer-review